Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Summary
This is a prospective, multicenter, randomized controlled clinical study to evaluate the effect of using intelligent patient management system on medication adherence of HER2 positive breast cancer patients receiving pyrotinib treatment. Pyrotinib is a small molecule tyrosine kinase inhibitor that can irreversibly inhibit HER1, HER2, and HER4.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
964
Start Date
2024-04-30
Completion Date
2027-04-30
Last Updated
2025-05-06
Healthy Volunteers
Yes
Interventions
pyrotinib
Intelligent patient management system on medication adherence of HER2 positive breast cancer patients receiving pyrotinib treatment.
Locations (1)
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China